COVID-19 Vaccine Confidence Among Pregnant Women and Mothers

Pregnancy Related Clinical Trial

— VCCOVID  

Official title:

Vaccine Confidence Among Pregnant Women and Mothers During the COVID-19 Pandemic

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04694664
• Other study ID #: 0003
• Status: Completed
• Start date: October 1, 2020
• Est. completion date: December 1, 2020

Study information

• Verified date: January 2021
• Source: Pregistry
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to assess the level of vaccine confidence and influencers among pregnant women and mothers of school-aged children during the COVID-19 pandemic.

Description:

The WHO has listed "vaccine hesitancy" as one of the top threats to global health. The COVID-19 pandemic has triggered the need to vaccinate worldwide as soon as a safe and efficacious vaccine becomes available. However preliminary data show that, on average, only 50% to 66% of US adults would be willing to receive COVID-19 vaccination when it becomes available, a percentage lower than what is required for herd immunity to control the pandemic. Furthermore, there is a pressing need to vaccinate children to reopen schools and keeping them safe, as well as to immunize pregnant women through vaccination programs since they constitute a vulnerable population. Vaccine confidence among pregnant women and mothers of school-aged children during the period of COVID-19 pandemic is unknown, leading to an important gap of knowledge that may hinder the upcoming global COVID-19 vaccination scale-up effort. It is therefore of critical importance to assess the level of vaccine confidence and influencers among pregnant women and mothers of school-aged children during the COVID-19 pandemic. The international nature of the proposed survey will allow the evaluation of vaccine confidence and its influencers among pregnant women and mothers of school-aged children on a global level. Therefore, social and geographic characteristics from different countries and cultures will be available for comparison. The resulting knowledge will be relevant to a large percentage of the world's population. Any country in the world can participate.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 18000
• Est. completion date: December 1, 2020
• Est. primary completion date: December 1, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Pregnant women or women who have at least one child younger than 18 years of age. Able to give electronic informed consent

Exclusion Criteria:

• <18 years of age

Related Conditions & MeSH terms

• Mothers
• Pregnancy Related

Intervention

Other:
• This is an online survey with no intervention.
As this is an online survey about health and wellbeing, there is no intervention.

Locations

Country	Name	City	State
United States	Pregistry	Los Angeles	California

Sponsors (2)

Lead Sponsor	Collaborator
Pregistry	Harvard School of Public Health

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of acceptance of a COVID-19 vaccine	This outcome will evaluate the hesitancy or acceptance to a COVID-19 vaccine	up to 2 months